Cyrus Biotechnology, Inc.

CIK 1641241 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cyrus Biotechnology, Inc..

Recent SEC filings

FiledFormAccession number
May 8, 2026D/A0001641241-26-000001
Jul 16, 2025D0001641241-25-000003
Dec 31, 2024D0001641241-24-000003
Feb 29, 2024D0001641241-24-000002
Dec 2, 2021D/A0001641241-21-000003
Oct 6, 2021D/A0001641241-21-000002
Jul 7, 2021D0001641241-21-000001
Sep 17, 2020D0001641241-20-000001
Jul 27, 2017D0001641241-17-000002
Feb 21, 2017D0001641241-17-000001
Nov 16, 2016D0001641241-16-000003
Apr 6, 2016D0001641241-16-000002
May 6, 2015D0001641241-15-000001